Search General Info
Search Education
Search Partnering Companies
Cyclacel is a clinical-stage biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and DNA damage response biology.
Ticker:
CYCC; CYCCP
Exchange:
Nasdaq
Company Type:
Not Provided
Company Website:
Company HQ State:
New Jersey
Company HQ Country:
United States
Year Founded:
1997
Main Therapeutic Focus:
Lead Product in Development:
Fadraciclib
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
